Zúñiga, Clemente Humberto
Acosta, Blanca Isaura
Menchaca, Rufino
Amescua, Cesar A.
Hong, Sean
Hui, Lucia
Gil, Minchan
Rhee, Yong-hee
Yoon, Sangwook
Kim, Minji
Chang, Paul Y.
Kim, Yong Man
Song, Paul Y.
Betito, Katia
Funding for this research was provided by:
NKGen Biotech, Inc.
Article History
Received: 3 May 2024
Accepted: 20 January 2025
First Online: 12 February 2025
Declarations
:
: The protocol was reviewed by the institution’s research board (Research Ethics Committee of Tijuana Angeles Hospital, registration number 02 CEI 003 20180322, approval received May 7, 2020). All patients signed informed consent prior to study enrolment.
: Not applicable.
: Authors PYS, KB, PYC, LH, and SH are all current or past employees and shareholders of NKGen Biotech, Inc. which was the sponsor of this trial. Authors MG, YR, SY, MK, and YMK are all employees of NKMAX Co Ltd, a shareholder of NKGen Biotech, Inc.